00ce5fa2-1423-49b4-b61d-aa37be388b11Q1 — 1st Quarter - ReportConsulting firm.
HCR — Health IssuesIssues related to compounding and counterfeit drugs.
Government entities lobbied: Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); SENATE; White House Office
MMM — Medicare/MedicaidIssues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; White House Office
TAX — Taxation/Internal Revenue CodeMonitored issues related to the implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes and foreign-based multinationals. Monitor OECD negotiations on the Pillar II global minimum tax.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)Issues related to tariffs. Issues related to importation of counterfeit drugs.
Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); SENATE; Treasury, Dept of
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.